Dudediligence.

Rafael Holdings, Inc

RFLNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$165,000Jul ’24$128,000Oct ’24$77,000Jan ’25$362,000Apr ’25$350,000Jul ’25$240,000Oct ’25$211,000Jan ’26$179,000Apr ’26
Net income, by quarter
−$4.5MJul ’24−$9.0MOct ’24−$4.6MJan ’25−$4.8MApr ’25−$290,000Jul ’25−$9.8MOct ’25−$6.4MJan ’26−$4.2MApr ’26
Fiscal years, by the month each ended
LineJul 2021Jul 2022Jul 2023Jul 2024Jul 2025
Revenue$802,000$410,000$279,000$637,000$917,000
Gross profit−$2.4M−$3.1Mnone on file$483,000none on file
Operating income−$28.2M−$60.5M−$15.0M−$102.6M−$29.2M
Net income−$23.1M−$124.7M−$1.9M−$34.4M−$30.5M
Operating cash flow−$15.6M−$26.1M−$10.9M−$7.8M−$18.9M
Free cash flow−$15.8M−$26.1Mnone on file−$7.9M−$18.9M
Cash$7.9M$26.5M$21.5M$2.7M$52.8M
Shares outstanding16.5M19.8M23.3M23.7M29.4M